Brind.

Shionogi Begins Manufacturing Medicon OTC Cough Medicine

1 report, 1 independent Updated Oct 19
AI-generated briefing. Brind wrote this from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.

What happened

Some supportReported by 1 outlet

Shionogi began manufacturing Medicon OTC medicine on October 19, 2026. Medicon is an over-the-counter cough medicine containing dextromethorphan, which acts as a non-narcotic cough suppressant. The manufacturer warns that Medicon should not be taken alongside other cough medicines, cold medicines, sedatives, or certain oral antihistamines.

From stripes.com

Why it matters

Some supportBrind's analysis of the reports

The introduction of Medicon into the Japanese market provides consumers with a specific over-the-counter option for treating dry or persistent coughs. This product is available in Japanese drugstores and is positioned alongside other available cough medicines.

From stripes.com

Who's involved

  • ShionogiJapanese pharmaceutical company that manufactures Medicon OTC medicine
  • MediconThe over-the-counter cough medicine being manufactured
  • OsakaLocation of Shionogi's headquarters

Keep exploring

The entities involved

  • Shionogi

    Japanese pharmaceutical company

    Nothing else this week.

Coverage

Newest first; wire copies grouped